Aeterna Zentaris

Aeterna Initiates Phase III Study on AEZS-108
Yahoo/Zacks
Sat, 08/3/13 - 10:30 am
Aeterna Zentaris
AEZS-108
endometrial cancer
Aeterna Zentaris: First Patient Dosed for Phase 3 Registration Trial in Endometrial Cancer with Zoptarelin Doxorubicin (AEZS-108)
Yahoo/CNW Group
Wed, 07/31/13 - 09:15 am
doxorubicin
endometrial cancer
Aeterna Zentaris
Biotech Stocks Under Pressures, Focus On IPOs
Property Mentor Group
Fri, 07/26/13 - 11:37 am
IPOs
Sequenom
Invovio
Aeterna Zentaris
Sarepta
InterMune
Cryolife
BiogenIdec
Boston Scientific
Varian Medical
Warner Chilcott
Aeterna Zentaris to Raise US$7.8 Million in Registered Direct Offering
Yahoo
Thu, 07/25/13 - 10:58 am
Aeterna Zentaris
stock offering
Æterna Zentaris Management Discusses Q1 2013 Results - Earnings Call Transcript
Seeking Alpha
Wed, 05/8/13 - 11:40 am
earnings
Aeterna Zentaris
This Week in Biotech
Motley Fool
Sun, 03/17/13 - 11:40 am
Navidea Biopharmaceuticals
Sinovac Biotech
Aeterna Zentaris
Spectrum Pharmaceuticals
Aeterna Zentaris to Discontinue Phase 3 Trial in Multiple Myeloma with Perifosine Following Data Safety Monitoring Board Recommendation
Yahoo
Mon, 03/11/13 - 12:33 pm
Aeterna Zentaris
Multiple Myeloma
perifosine
4 Small Biotechs With Big Clinical Trials Presenting In 2013
Seeking Alpha
Wed, 01/30/13 - 11:03 am
perifosine
Aeterna Zentaris
Advaxis
GCS-100
La Jolla Pharmaceutical
APPY1
Venaxis
Aeterna Zentaris soars on U.S. FDA trial agreement
Reuters
Fri, 12/28/12 - 11:43 am
Aeterna Zentaris
AEZS-108
endometrial cancer
AEterna Zentaris And Progenics Pharmaceuticals - Rising From The Ashes In 2013?
Seeking Alpha
Tue, 12/18/12 - 12:33 pm
Aeterna Zentaris
Progenics
The Worst-Performing Biotechs in 2012 and 1 to Avoid in 2013
Motley Fool
Sun, 12/9/12 - 01:21 pm
Chelsea Therapeutics
Cell Therapeutics
Aeterna Zentaris
Progenics Pharmaceuticals
Aveo Pharmaceutical
Exelixis
Small Market Cap Pharmaceuticals With Large Catalysts Looming In 2013
Seeking Alpha
Fri, 11/30/12 - 12:17 pm
Aeterna Zentaris
Celsion
OncoSec Medical
Aeterna Zentaris: Late-Stage Drug Candidates Could Send Stock Higher
Seeking Alpha
Tue, 11/20/12 - 11:36 am
Aeterna Zentaris
AEZS-108
perifosine
AEZS-130
A Dismal 2012 May Make For A Good Entry Now For AEterna Zentaris
Seeking Alpha
Tue, 11/13/12 - 11:49 am
Aeterna Zentaris
This Week in Biotech
Motley Fool
Sun, 10/21/12 - 10:47 am
Aegerion
Isis Pharmaceuticals
Sanofi
NPS Pharmaceuticals
Aeterna Zentaris
Biotech Investors: Are We Blinded By Clinical Trials?
Seeking Alpha
Mon, 10/15/12 - 10:42 am
clinical trials
Abbott Labs
Aeterna Zentaris
Dendreon
Keryx
Biotech Weekend Recap: Clinical Trials, Company Files
Seeking Alpha
Sun, 10/14/12 - 11:04 am
Eli Lilly
Valeant Pharmaceuticals
Lexicon Pharmaceuticals
Sarepta Therapeutics
Amarin
NPS Pharmaceuticals
Aeterna Zentaris
Healthcare Business Review: WellPoint’s Reorganization, AEterna Zentaris Crater
Wall St Cheat Street
Sat, 10/13/12 - 11:59 am
Aeterna Zentaris
AEterna Zentaris' Pipeline Giving It A Lift As A Bottom Bounce Trade
Seeking Alpha
Thu, 10/11/12 - 11:42 am
Aeterna Zentaris
perifosine
Weekend Recap: Biotech Madness
Seeking Alpha
Sun, 10/7/12 - 11:47 am
Sarepta Therapeutics
Synta Pharmaceuticals
Arena Pharmaceuticals
Arqule
Amarin
Acadia
Aeterna Zentaris

Pages